|
[1]DU D, LIU Y, QIAN H, et al.The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma[J].Int J Mol Sci, 2014, 15 (4) :6441-6452.
|
|
[2]YANG Y, YU MW, YANG GW, et al.Research progress of SDF-1/CXCR4 axis and tumor metastasis[J].China Med Herald, 2016, 13 (33) :34-38. (in Chinese) 杨永, 于明薇, 杨国旺, 等.SDF-1/CXCR4轴与肿瘤转移研究进展[J].中国医药导报, 2016, 13 (33) :34-38.
|
|
[3]ARYA M, PATEL HR, WILLIAMSON M.Chemokines:Key players in cancer[J].Curr Med Res Opin, 2003, 19 (6) :557-564.
|
|
[4]BALKWILL F.Cancer and the chemokine network[J].Nat Rev Cancer, 2004, 4 (7) :540-550.
|
|
[5]NELSON RT, BOYD J, GLADUE RP, et al.Genomic organization of the CC chemokine mip-3alpha/CCL20/larc/exodus/SCYA20, showing gene structure, splice variants, and chromosome localization[J].Genomics, 2001, 73 (1) :28-37.
|
|
[6]SCHUTYSER ES, STRUYF S, van DAMME J.The CC chemokine CCL20 and its receptor CCR6[J].Cytokine Growth Factor Rev, 2003, 14 (5) :409-426.
|
|
[7]YAMAUCHI K, AKBAR SM, HORIIKE N, et al.Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma:Relationship with clinical factors and prognostic importance during therapy[J].Int J Mol Med, 2003, 11 (5) :601-605.
|
|
[8]KUCHARZIK T, HUDSON III J, WAIKEL R, et al.CCR6 expression distinguishes mouse myeloid and lymphoid dendritic cell subsets:Demonstration using a CCR6 EGFP knock-in mouse[J].Eur J Immunol, 2002, 32 (1) :104-112.
|
|
[9]HIESHIMA K, IMAI T, OPDENAKKER G, et al.Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver.Chemotactic activity for lymphocytes and gene localization on chromosome 2[J].J Biol Chem, 1997, 272 (9) :5846-5853.
|
|
[10]SCHMUTH M, NEYER S, RAINER C, et al.Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function[J].Exp Dermatol, 2002, 11 (2) :135-142.
|
|
[11]LUKACS NW, PROSSER DM, MARIA W, et al.Requirement for the chemokine receptor ccr6 in allergic pulmonary inflammation[J].J Exp Med, 2001, 194 (4) :551-555.
|
|
[12]National Health and Family Planning Commission of the People's Republic of China.Diagnosis, management, andtreatment of hepatocellular carcinoma (V2017) [J].J Clin Hepatol, 2017, 33 (8) :1419-1431. (in Chinese) 中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范 (2017年版) [J].临床肝胆病杂志, 2017, 33 (8) :1419-1431.
|
|
[13]HAN MS, MOON KS, LEE KH, et al.Brain metastasis from hepatocellular carcinoma:The role of surgery as a prognostic factor[J].BMC Cancer, 2013, 13:567.
|
|
[14]LIOTTA LA.An attractive force in metastasis[J].Nature, 2001, 410 (6824) :24-25.
|
|
[15]CARR BI, GUERRA V.HCC and its microenvironment[J].Hepatogastroenterology, 2013, 60 (126) :1433-1437.
|
|
[16]LEONARDI GC, CANDIDO S, CERVELLO M, et al.The tumor microenvironment in hepatocellular carcinoma (review) [J].Int J Oncol, 2012, 40 (6) :1733-1747.
|
|
[17]SAKON M, NAGANO H, DONO K, et al.Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy:Analysis based on tumor hemodynamics[J].Arch Surg, 2002, 137 (1) :94-99.
|
|
[18]DING XJ.Diagnostic and prognostic value of CCL20 in patients with hepatocellular carcinoma[D].Jinan:Shandong Univ, 2012. (in Chinese) 丁祥就.趋化因子CCL20对肝癌诊断和预后的价值研究[D].济南:山东大学, 2012.
|
|
[19]CHANG XL.Relationship between CCR6/CCL20/Th17 axis and vascular invasion and metastasis of hepatocellular carcinoma[D].Guangzhou:Guangzhou Med Univ, 2014. (in Chinese) 畅秀丽.CCL20/CCR6/Th17轴与肝细胞癌血管浸润转移关系探讨[D].广州:广州医科大学, 2014.
|
|
[20]HE H, WU J, ZANG M, et al.CCR6 (+) B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis[J].Am J Cancer Res, 2017, 7 (5) :1151-1163.
|
|
[21]LI WM, LIU HR.CCL20-CCR6 cytokine network facilitate treg activity in advanced grades and metastatic variants of hepatocellular carcinoma[J].Scand J Immunol, 2016, 83 (1) :33-37.
|
|
[22]UCHIDA H, IWASHITA Y, SASAKI A, et al.Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2006, 21 (1 Pt 1) :161-168.
|
|
[23] LU E, SU J, ZHOU Y, et al.CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway[J].Biomed Pharmacother, 2017, 85:486-492.
|
|
[24]HAN G, WU D, YANG Y, et al.Crk L meditates CCL20/CCR6-induced EMT in gastric cancer[J].Cytokine, 2015, 76 (2) :163-169.
|
|
[25]KAPUR N, MIR H, CLARK LII CE, et al.CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition[J].Br J Cancer, 2016, 114 (12) :1343-1351.
|
|
[26]GHADJAR P, LODDENKEMPER C, COUPLAND SE, et al.Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer[J].J Cancer Res Clin Oncol, 2008, 134 (11) :1181-1189.
|
|
[27]LIU BY, JIAYP, MA J, et al.Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer[J].ABBS, 2016, 48 (12) :1067-1074.
|
|
[28]ABIKO Y, NISHIMURA M, KASANO K, et al.Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma[J].Arch Oral Biol, 2003, 48 (2) :171-175.
|
|
[29]IKEDA S, KITADATE A, ITO M, et al.Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma[J].Oncotarget, 2016, 7 (12) :13563-13574.
|
|
[30]LI J, WANG FY, GUO SP.Expression and clinical significance of chemokine CCL20 and its receptor CCR6 in esophageal squamous carcinoma tissues[J].Chin Remed Clin, 2014, 14 (6) :748-749. (in Chinese) 李嘉, 王飞云, 郭石平.CCL20及其受体CCR6在食管鳞癌组织中的表达及意义[J].中国药物与临床, 2014, 14 (6) :748-749.
|
|
[31]ZENG W, CHANG H, MA M, et al.CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production[J].Exp Mol Pathol, 2014, 97 (1) :184-190.
|
|
[32]ZHANG X, HU Z, MENG A, et al.Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma[J].Oncology Letters, 2017, 14 (6) :8183-8189.
|
|
[33]BRAND S, OLSZAK T, BEIGEL F, et al.Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells[J].J Cell Biochem, 2006, 97 (4) :709-723.
|
|
[34]DELLACASAGRANDE J, SCHREURS OJF, HOFGAARD PO, et al.Liver metastasis of cancer facilitated by chemokine receptor CCR6[J].Scand J Immunol, 2003, 57 (6) :534-544.
|
|
[35]FUJII H, ITOH YK, YAMAUCHI N, et al.Chemokine CCL20 enhances the growth of Hu H7 cells via phosphorylation of p44/42MAPK in vitro[J].Biochem Biophys Res Commun, 2004, 322 (3) :1052-1058.
|
|
[36]LU E, SU J, ZHOU Y, et al.CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway[J].Biomed Pharmacother, 2017, 85:486-492.
|
|
[37]MARSIGLIANTE S, VETRUGNO C, MUSCELLA A.CCL20 induces migration and proliferation on breast epithelial cells[J].J Cell Physiol, 2013, 228 (9) :1873-1883.
|
|
[38]YE LY, CHEN W, BAI XL, et al.Hypoxia-induced epithelial-tomesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis[J].Cancer Res, 2016, 76 (4) :818-830.
|
|
[39]HOU KZ, FU ZQ, GONG H.Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition[J].World J Gastroenterol, 2015, 21 (2) :475-483.
|
|
[40]QIU W, WANG G, SUN X, et al.The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma[J].Med Oncol, 2015, 32 (3) :75.
|
DownLoad: